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Abstract Sinonasal teratocarcinosarcoma (SNTCS) is a
rare and highly malignant tumour with combined features
of a teratoma and carcinosarcoma. We report the ﬁrst case
of a SNTCS in 23 year old male treated with neo-adjuvant
chemotherapy followed by cranio-facial resection. The
resection specimen displayed cellular maturation in the
neuroectodermal component. The patient presented with a
short history of nasal obstruction, epistaxis and headache.
On imaging, a bone destroying lesion of left paranasal
sinuses and nasal cavity was identiﬁed. The diagnosis of
SNTCS could be offered only on the third biopsy which
showed heterogeneous admixture of primitive neuroecto-
dermal, epithelial and mesenchymal elements. An adequate
sampling with high index of suspicion is needed to catch
hold this rare tumor. Tumor was excised after 4 cycles of
neo-adjuvant chemotherapy. On microscopic examination,
it showed similar epithelial and mesenchymal components
as the pretreatment biopsies. However, the primitive neu-
roectodermal component displayed extensive neuronal
maturation. The undifferentiated neuroectodermal cells
were completely absent in the post chemotherapy speci-
men. This case throws light on the morphologic evidence
of chemotherapy induced maturation in the neuroectoder-
mal component within SNTCS, an event hitherto not
reported in the literature in case of SNTCS.
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Introduction
Sinonasal teratocarcinosarcoma (SNTCS) is an extremely
rare and a highly malignant tumour with combined features
of a teratoma and carcinosarcoma. First described as tera-
toid carcinosarcoma by Shanmugaratnam et al. [1], this
enigmatic entity was given its present name of teratocar-
cinosarcoma by Heffner et al. [2]. Unique in histologic
appearance, SNTCS is characterized by tissue heteroge-
neity, varying maturity with a variegated histologic
architecture comprising a complex interplay of neuroec-
todermal elements, epithelial and mesenchymal
proliferations. This histologic heterogeneity, a morphologic
hallmark of SNTCS also accounts for numerous diagnostic
errors in small biopsies.
SNTCS are highly malignant neoplasms treated with
surgery, with or without adjuvant therapies. Histologic
maturation of the undifferentiated components of the ter-
atocarcinosarcoma following chemotherapy has never been
reported, as the neo-adjuvant chemotherapy is never given
in SNTCS (Table 1).
Case Report
A 23-year old Indian male presented to Tata Memorial
Hospital with a 3-month history of nasal stufﬁness, nasal
bleeding, nasal twang in voice, anosmia and increasing
headache. His medical and social history was unremark-
able. On examination, he had fullness of the cheek and
nose on the left side. Lymphnodes, thyroid and salivary
glands were non-palpable. Tumour markers (serum alfa-
feto protein and beta-human chorionic gonadotropin) were
within normal limits. Radiographs and computerized–
tomography scans showed a large bone destroying and
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DOI 10.1007/s12105-008-0094-xheterogeneously enhancing lobulated mass involving the
left nasal cavity, maxillary, ethmoid and frontal sinuses,
right nasal cavity with intracranial and retrobulbar exten-
sion (Fig. 1a). His blood counts and biochemical
investigations were within normal limits.
A course of neoadjuvant chemotherapy comprising four
cycles of cisplastin and adriamycin was administered to the
patient. The post-chemotherapy MRI scan revealed a par-
tial response in the extracranial portion, with no response
in the intracranial part (Fig. 1b). Subsequently, an endo-
scopic-assisted craniofacial resection was performed on the
patient for a T3N0 sinonasal tumour.
The ﬁrst biopsy submitted revealed crushing artifacts,
predominantly large necrotic areas with few degenerating
atypical round cells within. Limited and degenerating
tumour tissue precluded an immunohistochemical evalua-
tion, and differential diagnoses of lymphoma, olfactory
neuroblastoma (ONB) and alveolar rhabdomyosarcoma
were suggested in this young patient. The second biopsy
revealed only malignant squamous epithelial component
showing basaloid features with ﬁbrous stroma without even
trace of round cells leading to the diagnosis of squamous
cell carcinoma. Review of the histopathologic features of
these two biopsies raised a suspicion of a SNTCS and a
generous biopsy was requested. The third biopsy, submit-
ted as multiple fragments, showed a heterogeneous
malignant tumour composed of three different elements in
a necrotic background (Fig. 2). Most preponderant was a
malignant round cell component, immunopositive for mic-
2 and NSE (neuron-speciﬁc enolase) representing primitive
neuroectodermal tissue occupying nearly 40% of the
tumour volume in the biopsy. This component was inti-
mately admixed with an epithelial component composed of
malignant squamous epithelium and benign glands lined by
cuboidal epithelium, embedded in mesenchymal tissue
composed of myoﬁbroblasts. No ganglion cells or neuro-
ﬁbrillary matrix was identiﬁed. On the basis of the speciﬁc
histomorphology, as seen in three biopsies, a conﬁdent
diagnosis of SNTCS was rendered.
Patient underwent a craniofacial resection for a T3N0
sinonasal tumour following the neo-adjuvant chemother-
apy. The specimen was received in multiple, partly
hemorrhagic soft-to-rubbery tan-coloured tissue bits, hav-
ing variegated appearance, the largest one measuring
2.5 9 2.0 9 1.0 cm. The entire tissue was submitted for
processing. On microscopy, the tumour was heterogeneous
and composed of intimate admixture of neuroectodermal,
epithelial and mesenchymal components (Fig. 3). The
neuroectodermal component was composed of immature
ganglions cells embedded in abundant neuroﬁbrillary
matrix (Fig. 4). Although all the 16 hematoxylin and eosin-
stained sections exhibited varying proportions of neuroﬁ-
brillary matrix, it was predominant in the intracranial
portion of the tumour. None of the sections showed prim-
itive neuroectodermal cells as seen in the pre-
chemotherapy biopsy. Embedded within the neuroﬁbrillary
Table 1 Antibodies used for tumour cell characterization
IHC Company Dilution
MIC2 Dako 1:100
NSE Dako 1:100
Synaptophysin Dako 1:100
Chromogranin Dako 1:100
GFAP Dako 1:1200
S100 Dako 1:600
NFP Dako 1:100
CK-7 Dako 1:100
HMWCK Dako 1:100
EMA Dako 1:200
P63 Dako 1:200
Vimentin Dako 1:200
SMA Dako 1:400
Fig. 1 a A large enhancing
mass in the nasoethmoidal
region with erosion of
cribriform plate and large
intracranial extension in the
anterior cranial fossa. (pre-
chemotherapy MRI). b
Decrease in the size of the mass
as compared to the
prechemotherapy MRI (Post-
chemotherapy MRI)
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malignant squamous elements and characteristic hybrid
squamo-glandular units were noted. A moderate atypia and
mitotic activity were demonstrated in the epithelial ele-
ments. Mesenchymal component was composed of
myoﬁbroblastic proliferation with collagenized stroma. No
obvious sarcomatous component was identiﬁed. Bone or
cartilage was not seen. Surgical margins were positive for
tumour. Scanty uninvolved brain paranchyma was also
noted. Mature neuronal component was immunoreactive to
neuroﬁlament protein (NFP) [1:100; DAKO] (Fig. 5), NSE
[1:100; Dako], synaptophysin [1:100; Dako], chromogra-
nin [1:100; DAKO] and GFAP [1:1200; DAKO]. S-100
protein was focally positive. It was immunonegative for
MIC2 [1:100; DAKO]. The glandular epithelial component
was immunoreactive to epithelial membrane antigen
[1:200; DAKO] and CK7 [1:100; DAKO] while the squa-
mous component was positive for high molecular weight
cytokeratin [1:100; DAKO] and p63 [1:200; DAKO]
(Fig. 6). Positive labelling with vimentin and smooth
muscle actin [1:400; DAKO] was observed in the mesen-
chymal component. There was no evidence of a
germinoma, embryonal carcinoma, yolk-sac tumour or
choriocarcinoma in any of the sections.
The patient had received radiotherapy postoperatively
and is free of disease 10 months post surgery.
Discussion
SNTCS is an extremely rare and highly malignant tumour
with a unique and complex histology. Very few articles
Fig. 2 a Admixture of the
primitive neuroectodermal &
benign mesenchymal
component, as seen in the
biopsy (2009 Hematoxylin &
Eosin). b Epithelial component
in the form of a dilated gland
with transition into squamous
epithelium surrounded by
benign mesenchymal
component (4009 Hematoxylin
& Eosin)
Fig. 3 a & b Various
components of the tumour in the
form of heterogeneous
admixture of glandular
structures, nodules of neural
tissue with neuroﬁbrillary
matrix and ﬁbroblastic stroma,
as seen in the resection
specimen. (A-1009, B-2009
Hematoxylin & Eosin)
Fig. 4 a Ganglion-like
neuronal cells embedded in
abundant mature neuroﬁbrillary
matrix (Hematoxylin & Eosin
4009). b Synaptophysin
reactivity in neuroﬁbrillary
matrix (4009)
Head and Neck Pathol (2009) 3:31–36 33mainly in the form of case reports and small series of cases
comprising not more than 20 cases are available in the
literature [2]. First described by Shanmugaratnam et al. [1]
in 1983 and variously reported in literature as teratoid
carcinosarcoma, mixed mesodermal tumour, malignant
teratoma and blastoma, this rare tumour was aptly termed
as ‘‘Teratocarcinosarcoma’’ by Heffner et al. in 1984 [2–4].
This neoplasm is nearly exclusive to the sinonasal tract
and arises from pluripotent cells of olfactory epithelium,
although rare cases with its primary occurrence in the
nasopharynx and oral cavity are reported in literature [2, 5–
8]. Majority of the cases occur in an elderly age group
(above 50 years) with a male predominance. However,
occasional case reports of its occurrence in children and a
single report in neonate are also available [6, 7]. Majority
of the patients present with a short history of nasal
obstruction with or without epistaxis and a bone destroying
lesion on radiology. Intracranial extension is commonly
noted. The radiology clearly indicates the malignant nature
but does not spell out the variegated appearance of the
lesion.
Histologically, teratocarcinosarcoma is a unique
tumour comprising varying combinations of epithelial,
mesenchymal and neuroectodermal components exhibiting
varying maturation. Epithelial component presents in the
form of glands lined by normal appearing columnar to
cuboidal and ciliated or nonciliated cells. A focal transition
of these glands to squamous epithelium forming morules is
noted as was also seen in the present case. Squamous
component can be malignant, benign and mature or ‘‘fetal-
appearing’’ where the cells have clear cytoplasm with
distinct cytoplasmic membrane. The presence of these
‘‘fetal-appearing’’ squamous cells is a diagnostic feature as
described by Heffner and Hyams [2]. Often, the benign
glandular structures are associated with a concentric layer
of smooth muscles giving rise to an organoid appearance
resembling the primitive bronchial or intestinal organoid
structure as seen in teratoma. The organoid pattern of
arrangement, irregular shape of the glands, presence of
squamous morules or foetal squamous cells and absence of
inﬂammatory response help to distinguish from normal
seromucinous glands entrapped in the subepithelial stroma
[2]. The poorly differentiated malignant epithelial tissue in
the form of sheets may lead to the misdiagnosis of sino-
nasal undifferentiated carcinoma or squamous carcinoma
in a biopsy specimen [9].
The mesenchymal component varies in cellularity and
may appear benign to atypical to malignant. Mostly, it is
composed of myoﬁbroblastic proliferation with collage-
nized stroma and less cellular myxoid stroma. Other mature
components include cartilage, bone, striated muscles and
smooth muscles. These elements may show cytologic
atypia and immaturity. Frank malignant sarcomatous
transformations such as rhabdomyosarcoma, osteogenic
sarcoma or ﬁbrosarcoma, though rare, are also documented
[2, 9–11]. However, in the present case, we did not
encounter any sarcomatous component.
Undifferentiated round cell component is always present
and offers a diagnostic clue [2, 9–11]. These undifferenti-
ated round cells may show varying degrees of
neuroectodermal and neuroendocrine differentiation mim-
icking ONB, neuroendocrine carcinoma. These are well
delineated by positive labelling with immunohistochemical
Fig. 5 a NFP positivity in the
nodules of immature neural
tissue with neuroﬁbrillary
matrix. b Note the immuno-
negativity in the mature
epithelial component seen in the
centre
Fig. 6 CK-7 immunoreactivity in the epithelial component (2009)
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(NSE), chromogranin, NFP and GFAP.
The histomorphology comprising three distinct ele-
ments is very speciﬁc for the diagnosis of
teratocarcinosarcoma [2, 9–11]. This variegated mor-
phology can lead to erroneous interpretation on small
biopsies containing only one or two of the three elements.
Multiple superﬁcial biopsies may show only benign
mesenchymal tissue with scattered benign glands. This
should not be dismissed as sinonasal polyp. Many cases
could also be diagnosed as poorly differentiated or
undifferentiated carcinoma, when malignant epithelial
component predominates. Clinicopathologic correlation
often indicates mismatch between biopsy ﬁndings and
imaging ﬁndings. History of rapid growth, destructive
lesion on radiology and combination of varied compo-
nents in different biopsies offer a deﬁnite clue to the
clinician to repeat the biopsy. The ﬁrst biopsy in our case
revealed only round cell component leading to the dif-
ferential diagnoses of lymphoma, olfactory neuroblastoma
and alveolar rhabdomyosarcoma. All of these entities
have different therapeutic protocols. The second biopsy
revealed the malignant squamous epithelial component,
which, if evaluated alone, would have led to the incorrect
diagnosis and treatment of a carcinoma. The mesenchy-
mal component seen in the background was mistaken for
host stromal response. In the present case, the diagnosis
of teratocarcinosarcoma could be rendered only after
meticulous evaluation of all the three biopsies together.
Young age of the patient was deﬁnitely a deterrent point
for SNTCS. However, high index of suspicion led to a
deﬁnitive diagnosis on third biopsy.
The histogenesis of this entity is not yet fully elucidated.
Although SNTCS comprise three types of tissue elements
or teratoid features, it should not be confused with ex-
tragonadal malignant germ cell tumour (GCT) which
possesses the potential to develop somatic as well as
nonsomatic (extra embryonic) structures. None of the
SNTCS, by deﬁnition, contain areas of embryonal carci-
noma, choriocarcinoma, yolk-sac tumour or seminoma.
They have less well-deﬁned organoid or teratoid structures,
less developed neuronal tissues and immature/fetal carti-
laginous elements as compared with the malignant
teratomas. Moreover, all germ cell tumour marker levels
(beta-HCG, AFP) are always normal in these tumours. It is
hypothesized that this tumour entity arises from primitive
pluripotent olfactory epithelial cells, with a capacity to
mature in different types of tissues and not from the germ
cell as in malignant GCT [2, 10].
Teratocarcinosarcoma is a highly malignant neoplasm
with extensive local destruction and intracranial extension
and requires prompt and aggressive management. The
average survival as reported by Heffner and Hyams is
1.7 years [2]. Optimal treatment for SNTCS is still
unknown. Combination of radiotherapy and chemotherapy
with surgery has been tried with limited success. Prog-
nostic signiﬁcance of the various histologic components
of SNTCS as also the role of chemotherapy has not yet
been separately evaluated. In the present case, the patient
was treated with a neoadjuvant chemotherapy regimen
followed by wide excision. A partial response in the form
of reduction in size was noted mainly in the extracranial
portion of the tumour as documented on the post-che-
motherapy MRI. The predominant component in ﬁrst and
third prechemotherapy biopsies was primitive neuroecto-
dermal tissue lacking maturation. The post-chemotherapy
resection specimen was also predominated by neuroecto-
dermal component mainly in the intracranial portion but it
exhibited varying degrees of differentiation/maturation in
the form of immature ganglion cells in abundant neuro-
ﬁbrillary matrix. This is in contrast to the usual response
to the chemotherapy seen in cases of carcinoma. The
primitive round cell component was completely missing
in this post-neoadjuvant chemotherapy specimen. The
morphology of the epithelial components, however,
remained unchanged in the post-chemotherapy specimen.
This morphologic cellular maturation evidenced by dis-
appearance of the MIC-2 positive undifferentiated/
primitive neuroectodermal component seen in pre-che-
motherapy biopsy coupled with the appearance of
abundant neuroﬁbrillary matrix in the post-chemotherapy
resection specimen is previously not reported in the cases
of SNTCS.
It is a well-known phenomenon that morphological
maturation of advanced neuroblastoma occurs as a result of
cytotoxic anti-tumour chemotherapy with or without mat-
uration-inducing agent, even though the actual mechanism
of maturation remains speculative [12]. Post-chemotherapy
maturation can also be observed in olfactory neuroblas-
toma (ONB). Miura K et al. [13] has reported a bonaﬁde
case of ONB which completely transformed into mature
ganglioneuroma after chemotherapy. However, maturation
can also be seen per primum, though rarely, in ONB which
are not treated with neo-adjuvant chemotherapy. Our case
exhibited varying degrees of differentiation/maturation in
the form of nodules of immature ganglion cells within
neuroﬁbrillary matrix. Because the neuronal maturation
was localized mainly in the intracranial portion of the
tumour in our case the possibility of the role played by
tissue milieu i.e., brain parenchyma in inducing maturation
needs further evaluation.
Although malignant teratoma and SNTCS are histolog-
ically as well as embryologically separate entities, this
post-chemotherapy maturation, to some extent, may be
comparable to that is seen in malignant teratomas treated
with chemotherapy.
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our institution, 14 cases had primitive neuroectodermal
component. These cases had received various treatment
modalities in the form of surgery with or without adjuvant
chemotherapy and radiotherapy. However, not even a
single case had received neo-adjuvant chemotherapy, as
in the present case. To the best of our knowledge, this is
the ﬁrst case in the English literature documenting the
morphologic maturation of neuroectodermal elements
following administration of chemotherapeutic agents in a
case of SNTCS. It remains to be seen if this post-che-
motherapy maturation of an undifferentiated, aggressive
round cell component to a more differentiated form holds
any prognostic signiﬁcance for better outcome in future
prospective studies. Also, this morphologic cellular mat-
uration suggests a very interesting possibility of the
potential role of chemotherapeutic agents as differentia-
tion-inducing agents in these highly malignant tumours
for which a potentially curative therapeutic regimen has
so far been elusive.
To conclude, the tissue heterogeneity in SNTCS often
leads to diagnostic errors, emphasizing the need for a high
index of suspicion. Neuronal maturation observed in the
post-chemotherapy resection specimen holds an early
promise for chemotherapeutic agents as differentiation-
inducing agents that may modify the course of the dis-
ease. When the size of mass does not reduce signiﬁcantly
following chemotherapy, a possibility of post-chemo-
therapy maturation in the neuro-ectodermal component
should be kept in mind. Prospective randomized studies
are necessary to study the effect of chemotherapy on the
other components and to evaluate the prognostic signiﬁ-
cance of post-chemotherapy maturation in various
components. This case is under close observation to
evaluate the ﬁnal outcome.
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